STRATA CRITICAL MEDICAL INC CLASS (SRTA) competitors & alternatives
Health Care · NASDAQ
STRATA CRITICAL MEDICAL INC CLASS (SRTA)'s top competitors and alternatives — its most similar public companies — include Cardinal Health (CAH), United Parcel Service (UPS), TRANSMEDICS GROUP INC (TMDX), Natera (NTRA), Insight Molecular Diagnostics Inc. (IMDX), CAREDX INC (CDNA), Abbott Laboratories (ABT), LIVANOVA PLC (LIVN), Sotera Health (SHC), Steris (STE), GE HealthCare (GEHC) and McKesson Corporation (MCK). These are STRATA CRITICAL MEDICAL INC CLASS's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top SRTA competitors & alternatives
-
Cardinal HealthCAHHealth Care
Cardinal Health is a healthcare services and logistics company that distributes pharmaceuticals, medical supplies, and healthcare IT solutions to pharmacies,…
$220.54 (as of 2026-07-22) · market cap $53.0B
-
United Parcel ServiceUPSIndustrials
A global leader in logistics and package delivery, leveraging a massive integrated air-ground network and advanced smart-labeling technology to connect the…
$115.84 (as of 2026-07-22) · market cap $99.1B
-
TRANSMEDICS GROUP INCTMDXHealth Care
TransMedics commercializes the only FDA-approved portable warm perfusion platform for multi-organ transplantation, replacing cold storage to dramatically…
$71.20 (as of 2026-07-22) · market cap $2.5B
-
NateraNTRAHealth Care
Natera uses proprietary blood-based cell-free DNA technology to deliver personalized genetic diagnostics for oncology, prenatal screening, and organ transplant…
$264.22 (as of 2026-07-22) · market cap $37.9B
-
Insight Molecular Diagnostics Inc.IMDXHealth Care
iMDx develops decentralized molecular diagnostic kits for transplant organ rejection monitoring using donor-derived cell-free DNA biomarkers, enabling in-house…
$4.99 (as of 2026-07-22) · market cap $165M
-
CAREDX INCCDNAHealth Care
CareDx is the leading provider of genomics-based molecular diagnostics for transplant patients, combining non-invasive cell-free DNA and gene expression…
$37.78 (as of 2026-07-22) · market cap $2.0B
-
Abbott LaboratoriesABTHealth Care
Abbott Laboratories is a diversified healthcare giant providing a broad portfolio of diagnostic systems, medical devices, nutritional products, and established…
$100.57 (as of 2026-07-22) · market cap $175.1B
-
LIVANOVA PLCLIVNHealth Care
LivaNova is a medical technology company specializing in innovative cardiovascular and neuromodulation therapies to improve patient lives.
$78.27 (as of 2026-07-22) · market cap $4.3B
-
Sotera HealthSHCHealth Care
A global sterilization and lab testing partner ensuring the safety of medical devices and pharmaceuticals for 40+ top-50 device makers and 9 of top-10 pharma…
$17.29 (as of 2026-07-22) · market cap $4.9B
-
SterisSTEHealth Care
STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a…
$210.57 (as of 2026-07-22) · market cap $20.6B
-
GE HealthCareGEHCHealth Care
GE HealthCare is a leading medical technology company providing advanced diagnostic imaging, patient monitoring, and AI-driven clinical software to help…
$61.41 (as of 2026-07-22) · market cap $27.9B
-
McKesson CorporationMCKHealth Care
McKesson is a healthcare services giant that orchestrates the entire pharmaceutical and medical supply chain—from drug distribution and specialty oncology care…
$814.04 (as of 2026-07-22) · market cap $96.6B
Not quite? Describe exactly what you want →
Peers are STRATA CRITICAL MEDICAL INC CLASS's closest public companies by shared sub-industry, sector and business themes. See the full profile: STRATA CRITICAL MEDICAL INC CLASS (SRTA).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.